HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xianghua Fang Selected Research

Xianghua Fang Research Topics

Disease

7Stroke (Strokes)
12/2019 - 03/2012
5Hypertension (High Blood Pressure)
01/2021 - 01/2013
4Coronary Disease (Coronary Heart Disease)
01/2023 - 08/2008
4Ischemic Stroke
12/2019 - 08/2008
3Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 03/2012
3Dyslipidemias (Dyslipidemia)
01/2018 - 01/2013
2Chronic Disease (Chronic Diseases)
01/2023 - 01/2018
2Hyperhomocysteinemia
01/2020 - 05/2016
2Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2018
2Atherosclerosis
07/2019 - 05/2016
2Carotid Stenosis (Carotid Artery Stenosis)
07/2019 - 01/2018
2Myocardial Infarction
01/2019 - 01/2018
2Carotid Artery Diseases
01/2019 - 01/2018
2Heart Diseases (Heart Disease)
03/2016 - 01/2013
2Parkinson Disease (Parkinson's Disease)
12/2009 - 11/2009
1Cognitive Dysfunction
01/2020
1Hemorrhagic Stroke
12/2019
1Neoplasms (Cancer)
01/2018
1Lung Diseases (Lung Disease)
01/2018
1Renal Insufficiency (Renal Failure)
01/2018
1Liver Diseases (Liver Disease)
01/2018
1Hyperuricemia
05/2016
1Diabetes Mellitus
01/2013
1Parkinsonian Disorders (Parkinsonism)
12/2009

Drug/Important Bio-Agent (IBA)

5CholesterolIBA
01/2021 - 08/2008
3HomocysteineIBA
01/2020 - 01/2016
3HDL CholesterolIBA
12/2019 - 11/2011
3LipidsIBA
12/2019 - 11/2011
2Triglycerides (Triacylglycerol)IBA
01/2021 - 12/2019
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2018
2ORALIT (ORS)IBA
07/2019 - 05/2016
2Uric Acid (Urate)IBA
01/2019 - 05/2016
2C-Reactive ProteinIBA
01/2019 - 01/2016
2Levodopa (L Dopa)FDA LinkGeneric
12/2009 - 11/2009
1LDL CholesterolIBA
12/2019
1oxidized low density lipoproteinIBA
12/2019
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2018
1AD7c-NTPIBA
01/2018
1Fibrinogen (Factor I)FDA Link
03/2016
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2016
1AlbuminsIBA
01/2016

Therapy/Procedure

3Activities of Daily Living (ADL)
01/2021 - 03/2012
1Polypharmacy
01/2023
1Inappropriate Prescribing
01/2023
1Secondary Prevention
03/2012
1Therapeutics
12/2009